drug: carbidopa
- Clinical class: Anti-Parkinsonian (in combination with levodopa)
- Action: aromatic amino acid decarboxylase inhibitor
- CSA schedule: none
- DEA number: none
U.S. Preparations:
- Atamet (combination with levodopa; Athena) FDA approved indications: treatment of idiopathic Parkinson's disease, postencephalitic Parkinsonism and Parkinsonism which may follow toxic injury
- Carbidopa / Levodopa Tablets, USP
- Kinson (combination with levodopa; Alphapharm)
- Parcopa™ (combination with levodopa)
- Sinemet® (combination with levodopa)
- Sinemet® CR (combination with levodopa)
- Stalevo™ (Novartis) combination with levodopa and entacapone
Other Preparations:
- Lodosin, Lodosyn, Nu-Levocarb